Corbus Pharmaceuticals Holding (CRBP) — Working Capital to Net Assets Ratio
Corbus Pharmaceuticals Holding (CRBP) has a Working Capital to Net Assets ratio of 99.1% as of June 2026. Working capital of $101.27 Million (current assets of $122.75 Million minus current liabilities of $21.48 Million) is measured against net assets of $102.24 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see total assets of Corbus Pharmaceuticals Holding.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Corbus Pharmaceuticals Holding Working Capital to Net Assets (2012–2025)
This chart shows how Corbus Pharmaceuticals Holding's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 99.1%, reflecting working capital of $101.27 Million against net assets of $102.24 Million USD. Explore Corbus Pharmaceuticals Holding (CRBP) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Corbus Pharmaceuticals Holding (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Corbus Pharmaceuticals Holding from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read debt load of Corbus Pharmaceuticals Holding for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.2% | $146.26 Million | $147.50 Million | $166.95 Million | $20.69 Million | ▲ +0.1 pp |
| 2024 | 99.1% | $141.16 Million | $142.43 Million | $152.98 Million | $11.82 Million | ▼ -21.8 pp |
| 2023 | 120.9% | $-8.35 Million | $-6.91 Million | $23.55 Million | $31.89 Million | ▼ -23.2 pp |
| 2022 | 144.1% | $47.54 Million | $32.99 Million | $60.18 Million | $12.64 Million | ▲ +23.7 pp |
| 2021 | 120.4% | $83.20 Million | $69.11 Million | $100.20 Million | $17.01 Million | ▼ -12.5 pp |
| 2020 | 132.9% | $60.18 Million | $45.27 Million | $92.07 Million | $31.90 Million | ▲ +79.9 pp |
| 2019 | 53.1% | $3.27 Million | $6.16 Million | $38.15 Million | $34.89 Million | ▼ -42.0 pp |
| 2018 | 95.0% | $26.15 Million | $27.52 Million | $44.24 Million | $18.09 Million | ▼ -4.2 pp |
| 2017 | 99.2% | $57.30 Million | $57.78 Million | $65.50 Million | $8.20 Million | ▲ +3.8 pp |
| 2016 | 95.3% | $8.50 Million | $8.92 Million | $17.40 Million | $8.90 Million | ▼ -5.8 pp |
| 2015 | 101.1% | $9.08 Million | $8.99 Million | $12.71 Million | $3.63 Million | ▲ +2.3 pp |
| 2014 | 98.8% | $5.79 Million | $5.86 Million | $6.53 Million | $738.04K | ▲ +79.6 pp |
| 2013 | 19.3% | $-343.35K | $-1.78 Million | $305.52K | $648.87K | ▲ +154.4 pp |
| 2012 | -135.2% | $268.20 | $-198.38 | $544.98 | $276.78 | — |